Гипоталамические нонапептиды и канцерогенез: дискуссионные вопросы

Автор: Томчук Олеся Николаевна

Журнал: Морфологические ведомости @morpholetter

Статья в выпуске: 1 т.23, 2015 года.

Бесплатный доступ

В работе используются данные литературы по проблеме влияния гипоталамических нанопептидов, в частности окситоцина на рост и метастазирование опухоли.

Окситоцин, окситоциновые рецепторы, злокачественные новообразования

Короткий адрес: https://sciup.org/143177039

IDR: 143177039

Список литературы Гипоталамические нонапептиды и канцерогенез: дискуссионные вопросы

Стадников А.А. Фундаментальные и прикладные аспекты нейроэндокринной регуляции взаимодействий про-и эукариот/А.А. Стадников, Л.В. Ковбык, О.Л. Карташова//Известия Челябинского научного центра. -2001. -№ 4 (13). -С. 88-91.
Стадников А.А. О влиянии факторов супраоптических и паравентрикулярных ядер гипоталамуса на рост, клеточную репродукцию и цитодифференцировку эпителия аденогипофиза/А.А. Стадников, А.Л. Поленов//Российский физиологический журнал им. И.М. Сеченова. -1997. -Т. 83, № 8. -С. 65-73.
Стадников А.А. Фундаментальные и прикладные аспекты нейроэндокринной регуляции взаимодействий про-и эукариот/А.А. Стадников, Л.В. Ковбык, О.Л. Карташова//Известия Челябинского научного центра. -2001. -№4. -С 191-200
Григорьева М. Е. Окситоцин: строение, синтез, рецепторы и основные эффекты/М. Е. Григорьева, М. Г. Голубева//Нейрохимия. -2010. -№2. -С. 93-101.
Gimpl G. The oxytocin receptor system: structure, function, and regulation/G. Gimpl, F. Fahrenholz//Physiological Reviews. -2001. -V. 81. -Р. 629-683.
Стадников А.А., Бухарин О.В. Гипоталамическая нейросекреция и структурно-функциональный гомеостаз про-и эукариот (Морфологические основы реактивности, пластичности и регенера-ции)/А.А. Стадников, О.В. Бухарин. -Оренбург: ОрГМА, 2012. -296 с.
Стадников А.А. Роль гипоталамических нейропептидов во взаимодействиях про-и эукариот: структурно-функциональные аспекты./А.А. Стадников. -Екатеринбург: УрО РАН, 2001. -243 с.
Gimpl G. The oxytocin receptor system: structure, function, and regulation/G. Gimpl, F. Fahrenholz//Physiol. Rev. -2001. -V. 81. -Р. 629-683.
Donaldson Z.R. Oxytocin, vasopressin, and the neurogenetics of sociality/Z.R. Donaldson, L. J. Youn//Science. -2008. -V. 322. -№ 7. -P. 900-904.
Смирнов А.Н. Элементы эндокринной регуляции./А.Н. Смирнов. -М.: ГЭОТАР-Медиа, 2006. -351 с.
Ivell R. The structure and regulation of the oxytocin receptor/R. Ivell, T. Kimura, D. Muller, K. Augustin, N. Abend, R. Bathgate, R. Telgmann, M. Balvers//Exp. Physiol. -2001. -V. 86. -№ 2. -P. 289-296.
Kimura T. Structure and expression of a human oxytocin receptor/Kimura T. O., Tanizawa, K. Mori, M.J. Brownstein, H. Okayama//Nature. -1992. -V. 356. -P. 526-529.
Arias F. Pharmacology of oxytocin and prostaglandins/F. Arias//Clin Obstetric and Gynecology. -2000. -V. 43. -№ 3. -P. 455-468.
Huang W. Sodium excretion and renin secretion after continuous versus pulsatile infusion of oxytocin in rats/W. Huang, E. Jacobson, O. Skott, E.M. Stricker, A.F. Sved//J. Endocrinol. -1999. -V. 140. -N 6. -P. 2814-2818.
Мельников А.П. Окситоцин: современные представления о механизме действия и клиническом использовании/А.П. Мельников, В.А. Петрухин, В.А. Колесникова, Б.А. Слободянюк//Российский вестник акушера-гинеколога. -2009. -№. 3. -С. 19-26.
Terzidou V. Labor and Inflammation Increase the Expression of Oxytocin Receptor in Human Amnion/V. Terzidou, A.M. Blanks, S.H. Kim//Biol. Reprod. -2011. -V. 84. -Р. 546-552.
Viero C. Oxytocin: Crossing the bridge between basic science and pharmacotherapy CNS/C. Viero, I. Shibuya, N. Kitamura//Neuroscience & Therapeutics. -2010. -V. 16. -№ 5. -Р. 138-156.
Whittington K. Function and localization of oxytocin receptors in the reproductive tissue of rams/K. Whittington, S.J. Assinder, T. Parkinson//Reproduction. -2001. -V. 122. -Р. 317-325.
Зинчкеконко В.П. Внутриклеточная сигнализация./В.П. Зинчкеконко, Зинчкеконко, Л.П., Долгачева. Пущино: Аналитическая микроскопия, 2003. 84 c.
Филлипов П.П. Как внешние сигналы передаются внутри клетки/П.П. Филлипов//Соросовский образовательный журнал. -1998. -№3. -С. 28-34.
Кукес Ф.Г. Рецепторы в клинической фармакологии/Ф.Г. Кукес, В.П. Фисенко//Пособие для студентов медицинских ВУЗов, аспирантов и практических врачей. М.: Палея-М, 2001. 162с.
Тепляшина Е.А. Роль окситоцина и окситоциновых рецепторов в регуляции репродуктивных функций и фолликулогенеза/Е.А. Тепляшина, О.Л. Лопатина, М.В. Екимова, Е.А. Пожиленкова, А.Б.Салмина//Сибирский медицинский журнал. -2013. -№6. С. 21-25.
Тепляшина Е.А. Роль окситоцина и окситоциновых рецепторов в регуляции репродуктивных функций и фолликулогенеза/Е.А. Тепляшина, О.Л. Лопатина, М. В. Екимова, Е.А. Пожиленкова, А.Б. Салмина//Сибирский медицинский журнал. -2013. -№ 8. -С. 21-26.
Voss A.K. Oxytocin secretion by bovine granulosa cells: effects of stage follicular development, gonadotropins, and coculture with theca interna/A.K. Voss, J.E. Fortune//Endocrinology. -1991. -Vol. 128. -P. 1991-1999.
Devost D. Oxytocin-induced activation of eukaryotic elongation factor 2 in myometrial cells is mediated by protein kinase C/D. Devost, M. Carrier, H. Zingg//Endocrinology. -2008. -V. 149. -Р.131-138.
Rimoldi V. Oxytocin receptor elicits different EGFR/MAPK activation patterns depending on its localization in caveolin-1 enriched domains/V. Rimoldi, A. Reversi, E. Taverna,//Oncogene. -2003. -V. 22. -Р. 6054-6060.
Thibonnier M. Human vascular endothelial cells express oxytocin receptors/M. Thibonnier, D.M. Conarty, J.A. Preston, C.L. Plesnicher, R.A. Dweik, S.C. Ersurum//Endocrinology. -1999. -V. 140. -Р. 1301.
Jankowski M. Oxytocin and its receptors are synthesized in the rat vasculature/M. Jankowski, D. Wang, F. Hajjar, S. Mukaddam-Daher, S.M. McCann, J. Gutkowska//Proc. Natl. Acad. Sci. USA. -2000. -V. 97. -Р. 6207-6211.
Svanstrom M.C. Signs of myocardial ischaemia after injection of oxytocin: a randomized double-blind comparison of oxytocin and methylergometrine during/M.C. Svanstrom, B. Biber, M. Hanes, G. Johansson, U. Naslund, E. M. Balfors//Br. J. Anesthesia. -2008. -V. 100. -№5. -P. 683-689.
Taylor A.H. Interaction of vasopressin and oxytocin with human breast carcinoma cells./A.H. Taylor, V.T. Ang, J.S. Jenkins, J.J. Silverlight, R.C. Coombes, Y.A. Luqmani//Cancer Res. -1990. -№50. -Р. 7882-7886.
Cassoni P. Oxytocin inhibits proliferation of human breast cancer cell lines./P. Cassoni, A. Sapino, F. Negro, G. Bussolati//Virchows Arch. -1994. -№ 425.-P. 467-72.
Gutkowska J. Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart./J. Gutkowska, M. Jankowski, C. Lambert, D.S. Mukaddam, H.H. Zingg, Mc S.M. Cann//Proc. Natl. Acad. Sci. USA. -1997. -V. 94. -Р. 11 704-11 709.
Douglas A.J. Quo vadis neurohypophysial hormone research?/A.J. Douglas, M. Ludwig//Exp. Physiol. -2000. -V. 85. -P. 267-272.
Kimura T., Saji F., Nishimori K., Ogita K., Nakamura H., Koyama M., Murata Y. Molecular regulation of the oxytocin receptor in peripheral organs/T. Kimura, F. Saji, K. Nishimori, K. Ogita, H. Nakamura, M. Koyama, Y. Murata//J. Molecular Endocrinol. -2003. -V. 30. -№ 2. -P. 109-115.
Arpin-Bott M.P Historadioautographic localization of oxytocin and V1a vasopressin binding sites in the kidney of developing and adult rabbit, mouse and merione and of adult human/M.P. Arpin-Bott, B. Kaissling, E. Waltisperger, M. Rahin, P. Saussine, M.J. Freund-Mercier, M.E. Stoeckel//Exp. Nephrol. -2002. -V. 10. -№ 3. -Р. 196-208.
Copland A.J. Functional oxytocin receptors discovered in human osteoblasts/A.J. Copland, K.L. Ives, D.J. Simmons, M.S. Soloff//J. Endocrinol. -1999. -V. 140. -Р. 4371-4375.
Cassioni P. Oxytocin receptors in human adenocarcinomas of the endometrium: presence and biological significance/P. Cassioni, E. Fulcheri, M.L. Carcangiu, A. Stella, S. Deaglino, G. Bussolati//J. Pathol. -2000. -V. 190. -P. 470-477.
Cassoni P. Oxytocin induces proliferation and migration in immortalized human dermal microvascular endothelial cells and human breast tumor-derived endothelial cells/P. Cassoni, T. Marrocco, B. Bussolati, E. Allia, I. Munaron, A. Sapino, A. Bussolati//Molecul. Cancer Res. -2006. -№ 4. -Р. 351-359.
Голубева М.Г. Участие адренорецепторов в реакциях системы гемостаза на введение дез-глицил-амид-аргинил-вазопрессина./М.Г. Голубева, Т.М. Калишевская, М.Е. Соловьева//Вестн. МГУ. Сер. биол. -1999. -Т. 36. -№ 3. -С. 25-30.
Russell J.A. Sex, parturition and motherhood without oxytocin?/J.A. Russell, G. Leng//J. Endocrinol. -1998. -V. 75. -P. 343-359.
Фролов Б.А. Физиология и патология нейроэндокринной регуляции./Б.А. Фролов -М.: Медицина, 2006. 320 с.
Nishimori K. Oxytocin is required for nursing but is not essential for parturition or reproductive behavior./K. Nishimori, L.J. Young, Q. Guo, Z. Wang, T.R. Insel, M.M. Matzuk//Proc Natl Acad Sci USA. -1996. -№ 93. -Р. 11699-11704.
Olins G.M. Oxytocin-stimulated myosin phosphorylation in mammary myoepithelial cells: roles of calcium ions and cyclic nucleotides./G.M. Olins, R.D. Bremel//Endocrinology. -1984. -№ 114. -Р. 1617-1626.
Cassoni P. Oxytocin synthesis within the normal and neoplastic breast: First evidence of a local peptide source/P. Cassoni, T. Marrocco, A. Sapino, E. Allia, G.Bussolati//International journal of oncology. -2006. -№ 28. -P. 1263-1268.
Ширшев С.В. Механизмы действия белково-пептидных гормонов, катехоламинов и простагландинов (глава 2.2)/С.В. Ширшев//Механизмы иммуноэндокринного контроля процессов репродукции. Екатеринбург: УрО РАН, 2002. -Т.1. -С.161-202.
Лебедев В. Ф. Иммунотерапия рекомбинантным интерлейкином-2 тяжелых ранений и травм/В. Ф. Лебедев, В. К. Козлов, С. В. Гаврилин . -СПб.: Изд-во Санкт-Петерб. ун-та. -2002. -72 с.
Самотруева М.А. Пути реализации нейро-иммуно-эндокринных взаимодействий/М.А. Самотруева, Д.Л. Теплый, И.Н. Тюренков//Естественные науки. -2009. -№ 4. -С. 112-130.
Cassoni P. Oxytocin is a growth factor for Kaposi's sarcoma cells: evidence of endocrine-immunological cross-talk./P. Cassoni, A. Sapino, S. Deaglio, B. Bussolati, M. Volante, L. Munaron, A. Albini, A. Torrisi, G. Bussolati//Res. -2002. -№ 62. -P. 2406-2413.
Rauk P. N. Interleukin-1β down-regulates the oxytocin receptor in cultured uterine smooth muscle cells./P.N. Rauk, U. Friebe-Hoffman//Am. J. Reprod. Immunol. -2000. -№ 43. -P. 85-91.
Schmid B. Transcriptional regulation of oxytocin receptor by interleukin-1ß and interleukin-6./B. Schmid, S. Wong, B.F. Mitchell//Endocrinology. -2001. -№142. -P. 1380-1385.
Cassoni P. Oxytocin inhibits proliferation of human breast cancer cell lines./P. Cassoni, A. Sapino, F. Negro, G. Bussolati//Virchows Arch -1994. -№ 425. Р. -467-472.
Cassoni P. Oxytocin and oxytocin-analogue F314 inhibit cell proliferation and tumor growth of rat and mouse mammary carcinomas./P. Cassoni, A. Sapino, M. Papotti, G. Bussolati//Int J Cancer. -1996. -№ 66. -P. 817-820.
Cassoni P. Oxytocin synthesis within the normal and neoplastic breast: First evidence of a local peptide source/P. Cassoni, T. Marrocco, A. Sapino, E. Allia, G. Bussolati//international journal of oncology. -2006. -№ 28. -P. 1263-1268.
Péqueux C. Oxytocin synthesis and oxytocin receptor expression by cell lines of human small cell carcinoma of the lung stimulate tumor growth through autocrine/paracrine signaling./C. Pequeux, C. Breton, J.C. Hendrick, M.T. Hagelstein, H. Martens, R. Winkler, V. Geenen, J.J. Legros//Cancer Res. -2002. -№62. -P. 4623-4629.
Tahara A. Pharmacologic characterization of the oxytocin receptor in human uterine smooth muscle cells./A. Tahara, J. Tsukada, Y. Tomura, K. Wada, T. Kusayama, N. Ishii, T. Yatsu, W. Uchida, A. Tanaka//Br J Pharmacol. -2000. -№ 129. -P. 131-139.
Lucas R.L. Astroglia proliferate in response to oxytocin and vasopressin./R.L. Lucas, A.K. Salm//Brain Res -1995. -№ 681. -P. 218-222.
Petersson M. Oxytocin stimulates proliferation of human osteoblast-like cells./M. Petersson, A. Lagumdzija, A. Stark, E. Bucht//Peptides. -2002. -№ 23. -P. 1121-1126.
Ito Y. Investigation of the oxytocin receptor expression in human breast cancer tissue using newly established monoclonal antibodies./Y. Ito, T. Kobayashi, T. Kimura, N. Matsuura, E. Wakasugi, T. Takeda, T. Shimano, Y. Kubota, T. Nobunaga, Y. Makino, C. Azuma, F. Saji, M. Monden//Endocrinology. -1996. -№ 137. -P. 773-779.
Fay M.J. Oxytocin does not induce a rise in intracellular free calcium in human breast cancer cells./M.J. Fay, K.A. Longo, W.G. North//Res Comun Mol Pathol Pharmacol. -1999. -№ 103. -P. 115-128.
Amico J.A. Estradiol and progesterone regulate oxytocin receptor binding and expression in human breast cancer cell lines./J.A. Amico, P.N. Rauk, H.M. Cai//Endocrine. -2002. -№ 18. -P. 79-84.
Cassoni P. Presence and significance of oxytocin receptors in human neuroblastomas and glial tumors./P. Cassoni, A. Sapino, N. Fortunati, G. Bussolati//Int J Cancer. -1998. -№ 77. -695-700.
Cassoni P. Oxytocin inhibits the proliferation of MDA-MB231 human breast-cancer cells via cyclic adenosine monophosphate and protein kinase A./P. Cassoni, A. Sapino, N. Fortunati, L. Munaron, B. Chini, G. Bussolati//Int J Cancer. -1997. -V. 72. -P. 340-344.
Guzzi F. Localization of the human oxytocin receptor in caveolin-1 enriched domains turns the receptor-mediated inhibition of cell growth into a proliferative response./F. Guzzi, D. Zanchetta, P. Cassoni, V. Guzzi, M. Francolini, M. Parenti, B. Chini//Oncogene. -2002. -№ 7. -P. 1658-1667.
Cassoni P. Oxytocin and oxytocin receptors in cancer cells and proliferation./P. Cassoni, A. Sapino, T. Marrocco, B. Chini, G. Bussolati.//J Neuroendocrinol. -2004. -№ 16. -P. 362-364
Reversi A. Receptor Signaling in Myoepithelial and Cancer Cells/A. Reversi, P. Cassoni, B. Chini//Journal of Mammary Gland Biology and Neoplasia. -2005. -№ 3. P. 364-367.
Rimoldi V. Oxytocin receptor elicits different EGFR/MAPK activation patterns depending on its localization in caveolin-1 enriched domains./V. Rimoldi, A. Reversi, E. Taverna, P. Rosa, M. Francolini, P. Cassoni, M. Parenti, B. Chini//Oncogene. -2003. -№ 22. -P. 6054-6060.
Morita T. Oxytocin inhibits the progression of human ovarian carcinoma cells in vitro and in vivo./T. Morita, K. Shibata, F. Kikkawa, H. Kajiyama, K. Ino, S. Mizutani//Int J Cancer. -2004. -№109. -P. 525-32.
Marchio S. Vascular endothelial growth factor-C stimulates the migration and proliferation of Kaposi's sarcoma cells./S. Marchio, L. Primo, M. Pagano, G. Palestro, A. Albini, T. Veikkola, I. Cascone, K. Alitalo, F. Bussolino//J. Biol. Chem. -1999. -№ 274. -P. 27617-27622.
Cassoni P. Oxytocin induces proliferation and migration in immortalized human dermal microvascular endothelial cells and human breast tumor-derived endothelial cells./P. Cassoni, T. Marroco, B. Bussolati, E. Allia, L. Munaron, A. Sapino, G. Bussolati//Mol Cancer Res. -2006. -№4. -351-359.
Grange C. Isolation and characterization of breast tumor-derived endothelial cells./C. Grange, B. Bussolati, S. Bruno, A. Sapino, G. Camussi//Oncol Rep. -2006. -№15. -P. 381-386.
Reversi A. The oxytocin receptor antagonist atosiban inhibits cell growth via a “biased agonist” mechanism./A. Reversi, V. Rimoldi, T. Marrocco//J Biol Chem 2005;№22:16311-8.
Thibonnier M. Human Vascular Endothelial Cells Express Oxytocin Receptors/M. Thibonnier, D. M. Conarty, J. A. Preston, C. L. Plesnicher, R. A. Dweik, S. C. Erzurum//Endocrinology. -1999. -Vol. 140. -№ 3. -P. 1301-1309.
Otani A. Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells./A. Otani, H. Takagi, K. Suzuma, Y. Honda//Circ Res. -1998. -№ 82. -P. 619 -628.
Thibonnier M. Human vascular endothelial cells express oxytocin receptors./M. Thibonnier, DM. Conarty, J.A. Preston, C.L. Plesnicher, R.A. Dweik, S.C. Erzurum//Endocrinology. -1999. -№ 140. -P. 1301-1309.
Cassoni P. Oxytocin is a growth factor for Kaposi's sarcoma cells: evidence of endocrine-immunological cross-talk./P. Cassoni, A. Sapino, S. Deaglio//Cancer Res. -2002. -№ 62. -P. 2406-2413.
Sapino A. Oxytocin receptor within the breast: biological function and distribution./Sapino A. P. Cassoni, A. Stella, G. Bussolati//Anticancer Res. -1998. -№ 18. -P. 2181-2186.
Cassoni P. Oxytocin inhibits the proliferation of MDA-MB231 human breast-cancer cells via cyclic adenosine monophosphate and protein kinase A./P. Cassoni, A. Sapino, N. Fortunati, L. Munaron, B. Chini, G. Bussolati//Int J Cancer. -1997. -№ 72. -P. 340-344.
Suzuki Y. Possible role of placental leucine aminopeptidase in the antiproliferative effect of oxytocin in human endometrial adenocarcinoma./Y. Suzuki, K. Shibata, F. Kikkawa, H. Kajiyama, K. Ino, S. Nomura, M. Tsujimoto, S. Mizutani//Clin Cancer Res. -2003. -№9. -P. 1528-1534.
Cassoni P. Oxytocin receptors in human adenocarcinomas of the endometrium: Presence and biological significance./P. Cassoni, E. Fulcheri, ML. Carcangiu, A. Stella, S. Deaglio, G. Bussolati//J Pathol. -2000. -№ 190. -P. 470-477.
Cassoni P. Evidence of oxytocin/oxytocin receptor interplay in human prostate gland and carcinomas./P. Cassoni, T. Marrocco, A. Sapino, E. Allia, G. Bussolati//Int J Oncol. -2004. -№ 25. -P. 899-904.
Reversi A. The oxytocin receptor antagonist atosi-ban inhibits cell growth via a “biased agonist” mechanism./A. Reversi, V. Rimoldi, T. Marrocco, P. Cassoni, G. Bussolati, M. Parenti, B. Chini//J Biol Chem. -2005. -№ 280. -Р. 16311-16318.
Cassoni P. Evidence of oxytocin/oxytocin receptor interplay in human prostate gland and carcinomas./P. Cassoni, T. Marrocco, A. Sapino, E. Allia, G. Bussolati//Int J Oncol. -2004. -№25. -P. 899-904.
Pequeux C. Oxytocin-and vasopressin-induced growth of human small-cell lung cancer is mediated by the mitogen-activated protein kinase pathway./C. Pequeux, B.P. Keegan, M.T. Hagelstein, V. Geenen, J.J. Legros, W.G. North.//EndocrRelatCancer. -2004. -№ 11. -P. 871-885.
Pequeux C. Oxytocin synthesis and oxytocin receptor expression by cell lines of human small cell carcinoma of the lung stimulate tumor growth through autocrine/paracrine signaling./C. Pequeux, C. Breton, J.C. Hendrick, M.T. Hagelstein, H. Martens, R. Winkler, V. Geenen, J.J. Legros//Cancer Res. -2002. -№62. -4623-4629.
Cassoni P. Presence and significance of oxytocin receptors in human neuroblastomas and glial tumors./P. Cassoni, A. Sapino, A. Stella, N. Fortunati, G. Bussolati//Int J Cancer. -1998. -№77. -P. 695-700.
Novak J.F. A plasmin-derived hexapeptide from the carboxyl end of osteocalcin counteracts oxytocinmediated growth inhibition of osteosarcoma cells./J.F. Novak, M.B. Judkins, M.I. Chernin, P. Cassoni, G. Bussolati, J.A. Nitche, S.K. Nishimoto.//Cancer Res. -2000. -№60. -P. 3470-3476.
Thibonnier M. Human vascular endothelial cells express oxytocin receptors./M. Thibonnier, D.M. Conarty, J.A. Preston, C.L. Plesnicher, R.A. Dweik, S.C. Erzurum//Endocrinology. -1999. -№ 140. -P. 1301-1305.
Cassoni P. Oxytocin is a growth factor for Kaposi's sarcoma cells: Evidence of endocrine-immunological cross-talk./P. Cassoni, A. Sapino, S. Deaglio, B. Bussolati, M. Volante, L. Munaron, A. Albini, A. Torrisi, G. Bussolati//Cancer Res. -2002. -№ 62. -P. 2406-2413.
Cassoni P. Oxytocin is a growth factor for Kaposi's sarcoma cells: evidence of endocrine-immunological cross-talk./P. Cassoni, A. Sapino, S. Deaglio, B. Bussolati, M. Volante, L. Munaron, A. Albini, A. Torrisi, G. Bussolati//Cancer Res. -2002. -№62. -P. 2406-2413.
Cassoni P. Oxytocin and oxytocin-analogue F314 inhibit cell proliferation and tumour growth of rat and mammary carcinomas./P. Cassoni, A. Sapino, M. Papotti, G. Bussolati//Int J Cancer. -1996. -№ 66. -P. 817-820.
Bakos J. Effect of oxytocin on neuroblastoma cell viability and growth./J. Bakos, V. Strbak, N. Ratulovska, Z. Bacova//Cell Mol Neurobiol. -2012. -№32. -891-896.
Morita T. Oxytocin inhibits the progression of human ovarian carcinoma cells in vitro and in vivo/T. Morita, K. Shibata, F. Kikkawa, H. Kajiyama, K. Ino, S. Mizutani//Int. J. Cancer. -2004. -№ 109. -P. 525-532
Cassoni P. Oxytocin inhibits proliferation of huma n breast cancer cell lines./P. Cassoni, A. Sapino, F. Negro, G. Bussolati//Virchows Arch. -1994. -№ 425. -P. 467-72.
Reversi A. Oxytocin Receptor Signaling in Myoepithelial and Cancer Cells/A. Reversi, P. Cassoni, B. Chini//Journal of Mammary Gland Biology and Neoplasia. -2005. -№ 3. P. 365-369.
Cassoni P. Presence and significance of oxytocin receptors in human neuroblastomas and glial tumors./P. Cassoni, A. Sapino, A. Stella, N. Fortunati, and G. Bussolati//Int. J. Cancer. -1998. -№ 77. -P. 695-700.
Cassoni P. Antiproliferative effect of oxytocin through specific oxytocin receptors in human neuroblastoma and astrocytoma cell lines./P. Cassoni, A. Sapino, A. Stella, G. Bussolati//Exp Med Biol. -1998. -№ 449. -P. 245-246.
Cassoni P. Presence and significance of oxytocin receptors in human neuroblastomas and glial tumors./P. Cassoni, A. Sapino, A. Stella, N. Fortunati, G. Bussolati//Int J Cancer. -1998. -№ 77. -P. 695-700.
Fay M. J. Oxytocin does not induce a rise in intracellular free calcium in human breast cancer cells./M.J. Fay, J. Du, K.A. Longo, W.G. North//Res Commun Mol Pathol Pharmacol. -1999. -№ 103. -P. 115-28.
Cassoni P. Oxytocin receptors in human adenocarcinoma of the endometrium: presence and biological significance./P. Cassoni, E. Fulcheri, M.L. Carcangiu, A. Stella, S. Deaglio, G. Bussolati//J Pathol. -2000. -№190. -P. 470-477.
Suzuki Y. Possible role of placental leucine aminopeptidase (P-LAP) in the antiproliferative effect of oxytocin in human endometrial adenocarcinoma./Y. Suzuki, K. Shibata, F. Kikkawa, H. Kajiyama, K. Ino, S. Nomura, M. Tsujimoto, S. Mizutani//Clin Cancer Res. -2003. -№ 9. -P. 1528-1534.
Mignon C. Assignment of the human membranetype matrix metalloproteinase (MMP14) gene to 14q11-q12 by in situ hybridization./C. Mignon, A. Okada, M.G. Mattei, P. Basset//Genomics. -1995. -№ 28. -P. 360-361.
Dery M-C. Oxytocin Increases Invasive Properties of Endometrial Cancer Cells Through Phosphatidylinositol 3-Kinase/AKT-Dependent Up-Regulation of Cyclooxygenase-1, -2, and X-Linked Inhibitor of Apoptosis Protein/M-C. Dery, P. Chaudhry, V. Leblanc, S. Parent, A. Fortier, E. Asselin//Biology of reproduction. -2011. -№ 85. -P. 1133-1142.
Morita T. Oxytocin inhibits the progression of human ovarian carcinoma cells in vitro and in vivo/T. Morita, K. Shibata, F. Kikkawa, H. Kajiyama, K. Ino, S. Mizutani//Int. J. Cancer. -2004. -№ 109. -P. 525-532.
Luo J. Supression of prostate cancer invasive potential and matrix metalloproteinase activity by E-cadherin transfection./J. Luo, D.M. Lubaroff, M. J. Hendrix//Cancer Res. -1999. -№ 59. -P. 3552-3556.
Yano T., Yamasaki H. Regulation of cellular invasion and matrix metaloproteinase activity in HepG2 cell by connexin 26 transfection/T. Yano, H. Yamasaki//Mol Carcinog. -2001. -V 31. -P 101-109.
Kajiyama H. Peptidase IV overexpression induces up-regulation of E-cadherin and tissue inhibitor of matrix metalloproteinases, resulting in decreased invasive potential in ovarian carcinoma cells/H. Kajiyama, F. Kikkawa, E. Khin, K. Shibata, K. Ino, S. Mizutani//Dipeptidyl Cancer Res. -2003. -V 63. -P. 2278 -2283.
Morita T. Oxytocin inhibits the progression of human ovarian carcinoma cells in vitro and in vivo/T. Morita, K. Shibata, F. Kikkawa, H. Kajiyama, K. Ino, S. Mizutani//Int J Cancer. -2004. -V. 109. -P 525-532.

Еще

Статья обзорная